Guest guest Posted November 30, 2002 Report Share Posted November 30, 2002 I was researching ATDs on the Stanford Highwire site and found this: A Saleh, G Fürst, J Feldkamp, E Godehardt, A Grust, and U Mödder " Estimation of antithyroid drug dose in Graves' disease: value of quantification of thyroid blood flow with color duplex sonography. " This is a German study published in Ultrasound Med Biol, August 1, 2001 - By using color-flow mapping of the thyroid arteries, researchers were able to calculate something called color pixel density (CPD). They found a strong correlation between this CPD and methimazole dosage. They felt this might be a tool for the endocrinologist to use in estimating a methimazole dose that would be needed to maintain euthyroidism in each patient. If this could be investigated, we could save all kinds of rollercoaster rides - using thyroid doppler ultrasound to estimate the optimal ATD dosage - at least with MMI, and maybe even PTU. Instead of fooling around with doses that are too high, too low, constantly changing doses, etc., this could tell us how much ATD is needed without the aggravating and time-consuming guesswork. Wonder if any endos know about this yet? Yeah, right! The times they are a changin' --- Chris Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.